BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36439445)

  • 1. Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images.
    Javed S; Qureshi TA; Gaddam S; Wang L; Azab L; Wachsman AM; Chen W; Asadpour V; Jeon CY; Wu B; Xie Y; Pandol SJ; Li D
    Front Oncol; 2022; 12():1007990. PubMed ID: 36439445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
    Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
    Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.
    Qureshi TA; Javed S; Sarmadi T; Pandol SJ; Li D
    Chin Clin Oncol; 2022 Feb; 11(1):1. PubMed ID: 35144387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Convolutional Neural Network-Assisted Feature Extraction for Diagnostic Discrimination and Feature Visualization in Pancreatic Ductal Adenocarcinoma (PDAC) versus Autoimmune Pancreatitis (AIP).
    Ziegelmayer S; Kaissis G; Harder F; Jungmann F; Müller T; Makowski M; Braren R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33322559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.
    Chen PT; Chang D; Yen H; Liu KL; Huang SY; Roth H; Wu MS; Liao WC; Wang W
    Radiol Imaging Cancer; 2021 Jul; 3(4):e210010. PubMed ID: 34241550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 7. An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma.
    Vezakis I; Vezakis A; Gourtsoyianni S; Koutoulidis V; Polydorou AA; Matsopoulos GK; Koutsouris DD
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma.
    Park S; Sham JG; Kawamoto S; Blair AB; Rozich N; Fouladi DF; Shayesteh S; Hruban RH; He J; Wolfgang CL; Yuille AL; Fishman EK; Chu LC
    AJR Am J Roentgenol; 2021 Nov; 217(5):1104-1112. PubMed ID: 34467768
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative Radiomic Features From Computed Tomography Can Predict Pancreatic Cancer up to 36 Months Before Diagnosis.
    Chen W; Zhou Y; Asadpour V; Parker RA; Puttock EJ; Lustigova E; Wu BU
    Clin Transl Gastroenterol; 2023 Jan; 14(1):e00548. PubMed ID: 36434803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.
    Zaid M; Elganainy D; Dogra P; Dai A; Widmann L; Fernandes P; Wang Z; Pelaez MJ; Ramirez JR; Singhi AD; Dasyam AK; Brand RE; Park WG; Rahmanuddin S; Rosenthal MH; Wolpin BM; Khalaf N; Goel A; Von Hoff DD; Tamm EP; Maitra A; Cristini V; Koay EJ
    Front Oncol; 2020; 10():596931. PubMed ID: 33344245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy.
    Salinas-Miranda E; Khalvati F; Namdar K; Deniffel D; Dong X; Abbas E; Wilson JM; O'Kane GM; Knox J; Gallinger S; Haider MA
    Can Assoc Radiol J; 2021 Nov; 72(4):605-613. PubMed ID: 33151087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced computed tomography radiomics and multilayer perceptron network classifier: an approach for predicting CD20
    Yu J; Li Q; Zhang H; Meng Y; Liu YF; Jiang H; Ma C; Liu F; Fang X; Li J; Feng X; Shao C; Bian Y; Lu J
    Abdom Radiol (NY); 2022 Jan; 47(1):242-253. PubMed ID: 34708252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma.
    Ren S; Qian LC; Cao YY; Daniels MJ; Song LN; Tian Y; Wang ZQ
    World J Gastrointest Oncol; 2024 Apr; 16(4):1256-1267. PubMed ID: 38660647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
    Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
    Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
    Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
    Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmentation of Pancreatic Subregions in Computed Tomography Images.
    Javed S; Qureshi TA; Deng Z; Wachsman A; Raphael Y; Gaddam S; Xie Y; Pandol SJ; Li D
    J Imaging; 2022 Jul; 8(7):. PubMed ID: 35877639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
    Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
    Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.